Seronegative antibody-mediated neurology after immune checkpoint inhibitors
Wilson R. et al, (2018), Annals of Clinical and Translational Neurology
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
Booth CAG. et al, (2018), Cancer cell, 33, 274 - 291.e8
BONE MARROW MYELOPOIESIS INDEPENDENTLY OF CANONICAL NOTCH SIGNALING
Duarte S. et al, (2018), HAEMATOLOGICA, 102, 456 - 456
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma.
Lee RJ. et al, (2018), Annals of oncology : official journal of the European Society for Medical Oncology, 29, 490 - 496
Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Cheung V. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S198 - S198
Phase 1b/2 study of binimetinib (BINI) in combination with nivolumab (NIVO) or NIVO plus ipilimumab (IPI) in patients (pts) with previously treated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) with RAS mutation.
Bendell JC. et al, (2018), JOURNAL OF CLINICAL ONCOLOGY, 36
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
Farmery JHR. et al, (2018), Scientific Reports, 8
Canonical Notch signaling is dispensible for adult steady-state and stress myelo-erythropoiesis.
Duarte S. et al, (2018), Blood
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Woodcock VK. et al, (2018), British Journal of Cancer
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.
Blagden S. et al, (2018), Wiley interdisciplinary reviews. RNA, 9
ANTI-VCAM-1 TARGETED MRI ALLOWS EARLIER DETECTION OF BRAIN METASTASES IN A XENOGRAFT MELANOMA MOUSE MODEL
Cheng V. et al, (2018), NEURO-ONCOLOGY, 20, 13 - 13
Color Atlas Of Clinical Hematology: Molecular and Cellular Basis of Disease
Hoffbrand AV. et al, (2018), 1 - 585
Genome-scale CRISPR/Cas9 screen identifies factors required for sensitivity to pyrimidine nucleoside analogs
Sarr A. et al, (2018), CANCER RESEARCH, 78
NuTide 302: A phase IB study to assess the safety, pharmacokinetics and clinical activity of NUC-3373 in combination with standard agents used in colorectal cancer treatment.
Blagden SP. et al, (2018), JOURNAL OF CLINICAL ONCOLOGY, 36
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting (vol 179, pg 471, 2017)
Eyre TA. et al, (2018), BRITISH JOURNAL OF HAEMATOLOGY, 180, 309 - 309
Surgical and Medical Management of Epithelial Ovarian Cancer
Fotopoulou C. et al, (2018), Dewhurst's Textbook of Obstetrics & Gynaecology, 884 - 904
The cost-effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma.
Prettyjohns M. et al, (2018), Br J Haematol, 180, 52 - 59
A Single-Cell Approach to Unraveling Abnormal Megakaryocyte Differentiation and Function in Myelofibrosis
Psaila B. et al, (2017), BLOOD, 130
Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
Di Genua C. et al, (2017), BLOOD, 130
Molecular and Functional Characterization of Disease-Propagating Stem Cells in Juvenile Myelomonocytic Leukemia
Louka E. et al, (2017), BLOOD, 130